The present invention relates to a novel method to determine CETP activity in a bodily fluid sample wherein the sample may contain an inhibitor of CETP activity. The effect of the inhibitor is preserved to provide a more accurate determination of CETP activity in the fluid. Kits for the practice of the method are also provided.

 
Web www.patentalert.com

> Methods of use of DNA encoding a human histamine receptor of the H3 subtype

~ 00382